Vitor Ottoboni Brunaldi

Vitor Ottoboni Brunaldi

Auto-generated profile, based on publicly available information

Vitor Ottoboni Brunaldi

Hospital das Clínicas (HCFMUSP), University of São Paulo School of Medicine, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
VBVitor Ottoboni Brunaldi
Vitor Ottoboni Brunaldi
PJPichamol Jirapinyo
Pichamol Jirapinyo
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
OOOssamu Okazaki
Ossamu Okazaki
WBWanderley M. Bernardo
Wanderley M. Bernardo
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

15 July 2018 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
IJIatagan R. Josino
Iatagan R. Josino
AMAntônio C. Madruga-Neto
Antônio C. Madruga-Neto
IRIgor Braga Ribeiro
Igor Braga Ribeiro
HGHugo G. Guedes
Hugo G. Guedes
VBVitor O. Brunaldi
Vitor O. Brunaldi
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
Background. The use of bougies and balloons to dilate benign esophageal strictures (BES) is a consolidated procedure. However, the amount of evidence available in scientific literature supporting which is the best technique is very low, despite the great prevalence and importance of such pathology. This systematic review with meta-analysis aims at comparing both techniques, providing good quality of evidence. Methods. We searched for randomized clinical trials (RCTs) published from insertion to November 2017, using MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, LILACS, and grey literature. After the data extraction, a meta-analysis was performed. The main outcomes were symptomatic relief and recurrence rate. The secondary outcomes were bleeding, perforation, and postprocedure pain. Results. We included 5 randomized clinical trials (RCTs), totalizing 461 patients. Among them, 151 were treated with bougie dilation and 225 underwent balloon dilation. Regarding symptomatic relief, recurrence, bleeding, and perforation rates, there were no differences between the methods. Concerning postprocedure pain, patients submitted to balloon dilation had less intense pain (RD 0.27, 95% IC −0.42 to −0.07, P=0.007). Conclusion. We conclude that there is no difference between bougie and balloon dilation of BESs regarding symptomatic relief, recurrence rate at 12 months, bleeding, and perforation. Patients undergoing balloon dilation present less severe postprocedure pain.

15 August 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
FBFabio Bustamante
Fabio Bustamante
VBVitor Ottoboni Brunaldi
Vitor Ottoboni Brunaldi
WBWanderley Marques Bernardo
Wanderley Marques Bernardo
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
EMEduardo Turiani H. de Moura
Eduardo Turiani H. de Moura
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

1 July 2020 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
VBVitor Ottoboni Brunaldi
Vitor Ottoboni Brunaldi
GFGalileu Ferreira Ayala Farias
Galileu Ferreira Ayala Farias
DRDaniel Tavares de Rezende
Daniel Tavares de Rezende
GCGabriel Cairo-Nunes
Gabriel Cairo-Nunes
DRDaniel Riccioppo
Daniel Riccioppo
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

2 March 2022 in Chinese Medical Journal
Verified
Journal Article
Open access
VBVitor Ottoboni Brunaldi
Vitor Ottoboni Brunaldi
MNManoel Galvao Neto
Manoel Galvao Neto
Since its first description in 2013, robust evidence supporting the efficacy and safety of the endoscopic sleeve gastroplasty (ESG) has been on the rise. A large case series and meta-analysis report supported results up to 24 months, while some other studies already described 5-year data. If associated with pharmacotherapy, the ESG may help one to achieve weight loss similar to that of surgical sleeve gastrectomy. Though the results of the ongoing randomized trials on ESG are awaited, currently available data support the clinical use of the ESG, especially for patients who are refusing or unfit for bariatric surgery.

8 August 2019 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
MBMohit Bhandari
Mohit Bhandari
SJSaransh Jain
Saransh Jain
WMWinni Mathur
Winni Mathur
SKSusmit Kosta
Susmit Kosta
MNManoel Galvao Neto
Manoel Galvao Neto
MFMathias Fobi
Mathias Fobi